|
[1]
|
Stress: Immunology and Inflammation
2024
DOI:10.1016/B978-0-12-817558-3.00019-6
|
|
|
|
|
[2]
|
Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials
Journal of Critical Care,
2024
DOI:10.1016/j.jcrc.2023.154507
|
|
|
|
|
[3]
|
Corticosteroid Use Exhibit Different Benefits in Pneumonia: A Sensitivity Analysis
Clinical Infectious Diseases,
2024
DOI:10.1093/cid/ciad763
|
|
|
|
|
[4]
|
2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia
Critical Care Medicine,
2024
DOI:10.1097/CCM.0000000000006172
|
|
|
|
|
[5]
|
Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis
BMJ Open Respiratory Research,
2024
DOI:10.1136/bmjresp-2023-002141
|
|
|
|
|
[6]
|
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials
Clinical Infectious Diseases,
2023
DOI:10.1093/cid/ciad496
|
|
|
|
|
[7]
|
Comments on “Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials”
Critical Care,
2023
DOI:10.1186/s13054-023-04619-y
|
|
|
|
|
[8]
|
Effect of corticosteroids on mortality in patients with community-acquired pneumonia
Critical Care,
2023
DOI:10.1186/s13054-023-04645-w
|
|
|
|
|
[9]
|
Final approval for corticosteroids in severe CAP? For sure, in septic shock
Critical Care,
2023
DOI:10.1186/s13054-023-04613-4
|
|
|
|
|
[10]
|
Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review
Cureus,
2023
DOI:10.7759/cureus.46893
|
|
|
|
|
[11]
|
Guidelines for the management of severe community-acquired pneumonia: one confusing recommendation
Intensive Care Medicine,
2023
DOI:10.1007/s00134-023-07182-w
|
|
|
|
|
[12]
|
Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
Critical Care,
2023
DOI:10.1186/s13054-023-04561-z
|
|
|
|
|
[13]
|
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia
Chest,
2023
DOI:10.1016/j.chest.2022.08.2229
|
|
|
|
|
[14]
|
Adrenal Dysfunction Caused by a Critical Condition During Extracorporeal Membrane Oxygenation
Russian Sklifosovsky Journal "Emergency Medical Care",
2023
DOI:10.23934/2223-9022-2023-12-1-66-77
|
|
|
|
|
[15]
|
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
European Respiratory Journal,
2023
DOI:10.1183/13993003.00735-2022
|
|
|
|
|
[16]
|
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia
Chest,
2023
DOI:10.1016/j.chest.2022.08.2229
|
|
|
|
|
[17]
|
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Intensive Care Medicine,
2023
DOI:10.1007/s00134-023-07033-8
|
|
|
|
|
[18]
|
Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
Critical Care,
2023
DOI:10.1186/s13054-023-04561-z
|
|
|
|
|
[19]
|
Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: An Overview on Mechanistic Insights and Clinical Benefit
International Journal of Molecular Sciences,
2023
DOI:10.3390/ijms241512138
|
|
|
|
|
[20]
|
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis
Journal of General Internal Medicine,
2023
DOI:10.1007/s11606-023-08203-6
|
|
|
|
|
[21]
|
Severe community-acquired pneumonia
European Respiratory Review,
2022
DOI:10.1183/16000617.0123-2022
|
|
|
|
|
[22]
|
Severe community-acquired pneumonia
European Respiratory Review,
2022
DOI:10.1183/16000617.0123-2022
|
|
|
|
|
[23]
|
Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial
Trials,
2022
DOI:10.1186/s13063-022-06404-8
|
|
|
|
|
[24]
|
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia
Chest,
2022
DOI:10.1016/j.chest.2022.08.2229
|
|
|
|
|
[25]
|
Corticosteroids in Community-Acquired Pneumonia: A Review of Current Literature
Journal of Pharmacy Technology,
2021
DOI:10.1177/8755122521995587
|
|
|
|
|
[26]
|
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
European Respiratory Journal,
2021
DOI:10.1183/13993003.02535-2020
|
|
|
|
|
[27]
|
Efficacy and safety of corticosteroids in acute respiratory distress syndrome: An overview of meta‐analyses
International Journal of Clinical Practice,
2021
DOI:10.1111/ijcp.14645
|
|
|
|
|
[28]
|
Corticosteroids for Treating Sepsis in Adult Patients: A Systematic Review and Meta-Analysis
Frontiers in Immunology,
2021
DOI:10.3389/fimmu.2021.709155
|
|
|
|
|
[29]
|
Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
Intensive Care Medicine,
2020
DOI:10.1007/s00134-020-06289-8
|
|
|
|
|
[30]
|
The role of steroids in severe CAP
Hospital Practice,
2020
DOI:10.1080/21548331.2020.1720215
|
|
|
|
|
[31]
|
The Efficacy, Safety, and Optimal Regimen of Corticosteroids in Sepsis
Critical Care Explorations,
2020
DOI:10.1097/CCE.0000000000000094
|
|
|
|
|
[32]
|
Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis
Journal of Intensive Care,
2020
DOI:10.1186/s40560-020-00464-1
|
|
|
|
|
[33]
|
Corticosteroid treatment for early acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials
Journal of Intensive Care,
2020
DOI:10.1186/s40560-020-00510-y
|
|
|
|
|
[34]
|
The Efficacy, Safety, and Optimal Regimen of Corticosteroids in Sepsis: A Bayesian Network Meta-Analysis
Critical Care Explorations,
2020
DOI:10.1097/CCE.0000000000000094
|
|
|
|
|
[35]
|
Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia
Medicine,
2019
DOI:10.1097/MD.0000000000016239
|
|
|
|
|
[36]
|
Corticosteroids for Community-Acquired Pneumonia
Chest,
2019
DOI:10.1016/j.chest.2019.06.017
|
|
|
|
|
[37]
|
Impact and Beneficial Critical Points of Clinical Outcome in Corticosteroid Management of Adult Patients With Sepsis: Meta-Analysis and GRADE Assessment
Frontiers in Pharmacology,
2019
DOI:10.3389/fphar.2019.01101
|
|
|
|
|
[38]
|
Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial)
Medicine,
2019
DOI:10.1097/MD.0000000000017278
|
|
|
|
|
[39]
|
Hot topics and current controversies in community-acquired pneumonia
Breathe,
2019
DOI:10.1183/20734735.0205-2019
|
|
|
|
|
[40]
|
Use of glucocorticoids in the critical care setting: Science and clinical evidence
Pharmacology & Therapeutics,
2019
DOI:10.1016/j.pharmthera.2019.107428
|
|
|
|
|
[41]
|
Corticosteroids for treating sepsis in children and adults
Cochrane Database of Systematic Reviews,
2019
DOI:10.1002/14651858.CD002243.pub4
|
|
|
|
|
[42]
|
Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia
Medicine,
2019
DOI:10.1097/MD.0000000000016239
|
|
|
|
|
[43]
|
Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia
Medicine,
2019
DOI:10.1097/MD.0000000000014636
|
|
|
|
|
[44]
|
Corticosteroids for treating sepsis in children and adults
Cochrane Database of Systematic Reviews,
2019
DOI:10.1002/14651858.CD002243.pub4
|
|
|
|
|
[45]
|
Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial)
Medicine,
2019
DOI:10.1097/MD.0000000000017278
|
|
|
|
|
[46]
|
Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia
Medicine,
2019
DOI:10.1097/MD.0000000000014636
|
|
|
|
|
[47]
|
Corticosteroids in Sepsis
Critical Care Medicine,
2018
DOI:10.1097/CCM.0000000000003262
|
|
|
|
|
[48]
|
Corticostéroïdes dans les pneumopathies aiguës communautaires : où en sommes-nous en 2018 ?
Revue des Maladies Respiratoires,
2018
DOI:10.1016/j.rmr.2018.01.009
|
|
|
|
|
[49]
|
Corticosteroids Reduce Mortality in Patients With Severe Community-Acquired Pneumonia
Clinical Infectious Diseases,
2018
DOI:10.1093/cid/ciy336
|
|
|
|
|
[50]
|
Adjunctive Therapies for Community-Acquired Pneumonia
Clinics in Chest Medicine,
2018
DOI:10.1016/j.ccm.2018.07.008
|
|
|
|
|
[51]
|
2018 recommendations for the management of community acquired pneumonia
Jornal Brasileiro de Pneumologia,
2018
DOI:10.1590/s1806-37562018000000130
|
|
|
|
|
[52]
|
Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis
JAMA Internal Medicine,
2018
DOI:10.1001/jamainternmed.2018.5849
|
|
|
|
|
[53]
|
Corticosteroids in Lung and Pleural Infections
Current Pulmonology Reports,
2018
DOI:10.1007/s13665-018-0197-0
|
|
|
|
|
[54]
|
Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis
Clinical Infectious Diseases,
2018
DOI:10.1093/cid/cix801
|
|
|
|
|
[55]
|
Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials
Journal of Cardiothoracic and Vascular Anesthesia,
2018
DOI:10.1053/j.jvca.2018.04.017
|
|
|
|
|
[56]
|
Emerging concepts in pleural infection
Current Opinion in Pulmonary Medicine,
2018
DOI:10.1097/MCP.0000000000000487
|
|
|
|
|
[57]
|
Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
Journal of Intensive Care,
2018
DOI:10.1186/s40560-018-0321-9
|
|
|
|
|
[58]
|
Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association
The Clinical Respiratory Journal,
2018
DOI:10.1111/crj.12674
|
|
|
|
|
[59]
|
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
Critical Care Medicine,
2018
DOI:10.1097/CCM.0000000000003262
|
|
|
|
|
[60]
|
Corticosteroids for pneumonia
Cochrane Database of Systematic Reviews,
2017
DOI:10.1002/14651858.CD007720.pub3
|
|
|
|
|
[61]
|
Corticosteroids for pneumonia
Cochrane Database of Systematic Reviews,
2017
DOI:10.1002/14651858.CD007720.pub3
|
|
|
|
|
[62]
|
Corticosteroids in septic shock: a systematic review and network meta-analysis
Critical Care,
2017
DOI:10.1186/s13054-017-1659-4
|
|
|
|
|
[63]
|
Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis
The American Journal of Emergency Medicine,
2017
DOI:10.1016/j.ajem.2017.07.050
|
|
|
|
|
[64]
|
Corticothérapie systémique et pneumopathies communautaires : où en est-on ?
Médecine Intensive Réanimation,
2017
DOI:10.1007/s13546-017-1254-8
|
|
|
|
|
[65]
|
Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association
The Clinical Respiratory Journal,
2017
DOI:10.1111/crj.12674
|
|
|
|
|
[66]
|
Corticosteroids in treating community-acquired pneumonia: has the time really come?
Clinical Microbiology and Infection,
2017
DOI:10.1016/j.cmi.2016.09.002
|
|
|
|
|
[67]
|
Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature
Intensive Care Medicine,
2016
DOI:10.1007/s00134-015-4095-4
|
|
|
|
|
[68]
|
Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: we are not sure
Intensive Care Medicine,
2016
DOI:10.1007/s00134-015-4160-z
|
|
|
|
|
[69]
|
Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia
Chest,
2016
DOI:10.1378/chest.15-1733
|
|
|
|
|
[70]
|
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
Frontiers in Pediatrics,
2016
DOI:10.3389/fped.2016.00058
|
|
|
|
|
[71]
|
Controversies in the Management of Community-Acquired Pneumonia
Current Emergency and Hospital Medicine Reports,
2016
DOI:10.1007/s40138-016-0107-0
|
|
|
|
|
[72]
|
Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial
Critical Care,
2016
DOI:10.1186/s13054-016-1511-2
|
|
|
|
|
[73]
|
Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis
PLOS ONE,
2016
DOI:10.1371/journal.pone.0165942
|
|
|
|
|
[74]
|
What is the role of corticosteroids in the management of sepsis?
Medwave,
2016
DOI:10.5867/medwave.2016.6522
|
|
|
|
|
[75]
|
Annual Update in Intensive Care and Emergency Medicine 2016
Annual Update in Intensive Care and Emergency Medicine,
2016
DOI:10.1007/978-3-319-27349-5_26
|
|
|
|
|
[76]
|
Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis
PLOS ONE,
2015
DOI:10.1371/journal.pone.0144032
|
|
|
|
|
[77]
|
Corticosteroids for all adult patients with community-acquired pneumonia?
Pneumonia,
2015
DOI:10.15172/pneu.2015.6/690
|
|
|
|
|
[78]
|
Managing CAP in the ICU
Current Infectious Disease Reports,
2015
DOI:10.1007/s11908-015-0504-7
|
|
|
|
|
[79]
|
Cochrane Database of Systematic Reviews
2015
DOI:10.1002/14651858.CD002243.pub3
|
|
|
|
|
[80]
|
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
The Lancet,
2015
DOI:10.1016/S0140-6736(14)62447-8
|
|
|
|
|
[81]
|
Corticosteroids and pneumonia: time to change practice
The Lancet,
2015
DOI:10.1016/S0140-6736(14)62391-6
|
|
|
|
|
[82]
|
Double-Blind, Placebo-Controlled Pilot Randomized Trial of Methylprednisolone Infusion in Pediatric Acute Respiratory Distress Syndrome
Pediatric Critical Care Medicine,
2015
DOI:10.1097/PCC.0000000000000349
|
|
|
|
|
[83]
|
Pneumonies aiguës communautaires: peut-on encore en améliorer le pronostic?
Revue des Maladies Respiratoires Actualités,
2015
DOI:10.1016/S1877-1203(15)30059-8
|
|
|
|
|
[84]
|
Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update
Scientific Reports,
2015
DOI:10.1038/srep14061
|
|
|
|
|
[85]
|
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
Annals of Internal Medicine,
2015
DOI:10.7326/M15-0715
|
|
|
|
|
[86]
|
Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update
Scientific Reports,
2015
DOI:10.1038/srep14061
|
|
|
|
|
[87]
|
Corticosteroids in the Treatment of Severe Community-Acquired Pneumonia
Current Infectious Disease Reports,
2014
DOI:10.1007/s11908-014-0405-1
|
|
|
|
|
[88]
|
Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
Trials,
2014
DOI:10.1186/1745-6215-15-257
|
|
|
|
|
[89]
|
Annual Update in Intensive Care and Emergency Medicine 2014
2014
DOI:10.1007/978-3-319-03746-2_5
|
|
|
|
|
[90]
|
Is Prolonged Low-Dose Glucocorticoid Treatment Beneficial in Community-Acquired Pneumonia?
Current Infectious Disease Reports,
2013
DOI:10.1007/s11908-013-0322-8
|
|
|
|
|
[91]
|
Current treatment of community-acquired pneumonia
Expert Opinion on Pharmacotherapy,
2013
DOI:10.1517/14656566.2013.798647
|
|
|
|
|
[92]
|
Adjuvant steroid therapy in community‐acquired pneumonia: A systematic review and meta‐analysis
Journal of Hospital Medicine,
2013
DOI:10.1002/jhm.1992
|
|
|
|
|
[93]
|
Adjuvant steroid therapy in community‐acquired pneumonia: A systematic review and meta‐analysis
Journal of Hospital Medicine,
2013
DOI:10.1002/jhm.1992
|
|
|
|
|
[94]
|
Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis
PLoS ONE,
2012
DOI:10.1371/journal.pone.0047926
|
|
|
|